AI

Closing the data loop in AI-driven drug discovery

MIT Tech Review · Mon, 27 Jul 2026 11:40:16 GMT

Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today,

Read original source Discuss with SiiMON